Empery Asset Management, LP 89bio, Inc. Transaction History
Empery Asset Management, LP
- $16.8 Million
- Q3 2022
A detailed history of Empery Asset Management, LP transactions in 89bio, Inc. stock. As of the latest transaction made, Empery Asset Management, LP holds 400,000 shares of ETNB stock, worth $3.87 Million. This represents 13.78% of its overall portfolio holdings.
Number of Shares
400,000
Previous 400,000
-0.0%
Holding current value
$3.87 Million
Previous $1.29 Million
79.81%
% of portfolio
13.78%
Previous 6.97%
Shares
1 transactions
Others Institutions Holding ETNB
# of Institutions
164Shares Held
108MCall Options Held
73.6KPut Options Held
1.19M-
Janus Henderson Group PLC London, X015.2MShares$147 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$137 Million1.46% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.99MShares$77.4 Million2.33% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$71.4 Million0.87% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$67.9 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $450M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...